Additional therapeutic effects may be achieved via CsA and tacrolimus» anti-inflammatory effects, stimulatory effect on lacrimal glands, proliferative effect on mucin - producing conjunctival goblet cells, and inhibitory effect on
lacrimal cell apoptosis.